Health Condition 1: null- Pancreas or periampullary
Conditions
Interventions
None listed
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients with histo- or cytopathologically proven pancreatic or periampullary cancer diagnosed between January 2012 and July 2015 in the Johns Hopkins Hospital, Baltimore, the Massachusetts General Hospital, Boston, the Beth Israel Deaconess Medical Center, Boston (all USA),the University of Verona Hospital Trust, Verona, Italy, the Dutch Pancreatic Cancer Group (DPCG), Tata Memorial Centre, Mumbai, India and the Seoul National University Hospital, Seoul, South Korea will be identified and will receive an electronic invitation to participate in the survey
Exclusion criteria
Exclusion criteria: Patients with a life expectancy of less than three months are excluded to ensure completion of both rounds
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The objective of this study is to internationally validate a core set of PROs to be used in pancreatic cancer care and research. â?? Timepoint: 1 year â?? | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient related outcomesTimepoint: 1 year | — |
Countries
India, Italy, Netherlands, Other, United States of America
Contacts
Public ContactShailesh Vinayak Shrikhande
Tata Memorial Hospital
Outcome results
None listed